Search results for: 'Pharma and Biotech M&A Trends 2009-2014'
- Did you mean
 - pharma and biotech m a trends 2016 2016
 
- Related search terms
 - Trends in Therapeutic Partnering
 - Trends in Therapeutic Partnering 2010 - 2015
 - trends in therapeutic partnering 2014 2015
 - trends in therapeutic partnering 2014 2020
 - trends in therapeutics partnering 2024 2024
 
- 
                
                    
                    Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2025August 2025$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2025
Learn More - 
                
                    
                    Global Biotech Partnering Terms and Agreements 2018-2023March 2023$3,995.00Global Biotech Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter biotech partnering deals.
Learn More - 
                
                    
                    Artificial Intelligence (AI) Collaboration and Licensing Deals in Pharma, Biotech and Diagnostics 2019-2025May 2025$3,995.00Artificial Intelligence (AI) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More - 
                
                    
                    Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More - 
                
                    
                    Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More - 
                
                    
                    Big Pharma Partnering Terms and Agreements 2020-2025July 2025$5,995.00Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals
Learn More - 
                
                    
                    Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2019-2025August 2025$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More - 
                
                    
                    Syndromic Multiplex Diagnostics: Strategies and Trends, Market Forecasts by Syndrome, Place, Product and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More - 
                
                    
                    Co-development Deals in Pharmaceuticals and Biotechnology 2016-2025September 2025$3,995.00Analyze co-development deals in pharma and biotech from 2016 to 2025. Includes financials, deal terms, and access to actual contracts where available.
Learn More - 
                
                    
                    Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025September 2025$3,995.00Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More 
